WM — Jan 28, 2026 release
Fiscal 2025 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001104659-26-007476
Showing in the filing
Return to shareholders through dividends and share repurchases
“approximately $3.5 billion”
Period
FY2026
Measure
Declared action
Source
Prose
All guidance in this release · 41
Return to shareholders through dividends and… for FY2026
“approximately $3.5 billion”
Shareholder returns (dividends and share rep… for FY2026
“approximately $3.5 billion”
Revenue for FY2026
“$26,425 - $26,625”
Revenue - Projected Year-Over-Year Change at… for FY2026
“Growth of 5.2%”
Adjusted operating EBITDA for FY2026
“$8,150 - $8,250”
Adjusted operating EBITDA - Projected Year-O… for FY2026
“Growth of 6.2% on a comparable basis, reflecting a change in the classification of accretion expense beginning in 2026 (i)”
Adjusted operating EBITDA margin for FY2026
“30.8%-31.0%”
Adjusted operating EBITDA margin - Projected… for FY2026
“Expansion of 30 basis points on a comparable basis, reflecting a change in the classification of accretion expense beginning in 2026, (i) or 50 basis points when normalized for the prior year wildfire cleanup”
Capital to support the business for FY2026
“$2,450 - $2,550”
Capital to support the business - Projected … for FY2026
“Reduction of about $100 million”
Sustainability growth capital (j) for FY2026
“About $200”
Sustainability growth capital (j) - Projecte… for FY2026
“Reduction of more than $400 million”
Free cash flow for FY2026
“$3,750 - $3,850”
Free cash flow - Projected Year-Over-Year Ch… for FY2026
“Growth of 29.4%”
Core price for FY2026
“between 5.4% and 5.8%”
Yield for FY2026
“between 3.2% and 3.6%”
Volumes for FY2026
“between 0.2% and 0.6%”
Rollover from solid waste acquisitions - rev… for FY2026
“about $65 million”
Revenue from rollover from solid waste acqui…
“about $65 million”
Rollover from solid waste acquisitions - adj… for FY2026
“$25 million”
Adjusted operating EBITDA from rollover from…
“$25 million”
Adjusted operating EBITDA growth for Recycli… for FY2026
“between $235 and $255 million”
Healthcare Solutions business revenue growth for FY2026
“around 3%”
Investment in solid waste acquisitions for FY2026
“$100 to $200 million”
Estimated annual dividends paid to sharehold… for FY2026
“$1.5 billion”
Increase in annual dividend for FY2026
“$0.48 per share”
Annual dividend per share for FY2026
“$3.78”
Resumption of share repurchases for Q1 FY2026
“first quarter of 2026”
Share repurchases for FY2026
“approximately $2 billion”
Leverage ratio target for FY2026
“between 2.5x and 3.0x”
Renewable natural gas plants to be completed for FY2026
“six additional”
Recycling projects to be completed for FY2026
“four additional”
Run-rate contributions from previously annou… for FY2027
“almost all of the full run-rate contributions from its previously announced projects”
Adjusted operating EBITDA for Recycling Proc… for FY2027
“approach $1 billion”
Accretion expense for FY2026
“approximately $150 million”
Capital spending on two recently approved re… for FY2026
“about $85 million”
Blended average single-stream recycled commo… for FY2026
“approximately $70 per ton”
Renewable natural gas generation for FY2026
“between 21 and 22 million MMBtu”
Contracted renewable natural gas price (60% … for FY2026
“about $27 per MMBtu”
Uncontracted/market-rate renewable natural g… for FY2026
“approximately $24.50 per MMBtu”
Overall anticipated blended average price of… for FY2026
“approximately $26 per MMBtu”
Exhibit 99.1 · the passage around this item
… earlier in the release
(a) This
growth is underpinned by our unreplicable solid waste network as well as the intentional investments we have made in recycling and renewable
energy projects, our fleet, and a premier medical waste network. We plan to harvest the benefits of our investments and return to shareholders
approximately $3.5 billion in 2026 through dividends and share repurchases while also returning our leverage ratio to our long-term target
range of between 2.5x and 3.0x.” (d)
KEY
HIGHLIGHTS FOR the fourth quarter and FULL YEAR 2025
Operating EBITDA (b)
Fourth Quarter 2025
Full Year 2025
($ in millions)
($ in millions)
Total Company
Breakout
As
Adjusted (a)
Total Company
Breakout
As
Adjusted (a)
Amount
Margin
Amount
Margin
Amount
Margin
Amount
Margin
Legacy Business (e)
$ 1,838
32.3 %
$ 1,869
32.8 %
$ 6,833
30.1 %
$ 7,158
31.5 %
Healthcare Solutions
87
14.1 %
105
17.1 %
338
13.5 %
424
16.9 %
Total Company
$ 1,925
30.5 %
$ 1,974
31.3 %
$ 7,171
28.5 %
$ 7,582
30.1 %
· Total Company operating EBITDA grew 13.3% in 2025. On an adjusted basis, total Company operating EBITDA
grew 15.5%, and full-year adjusted margin exceeded 30% for the first time. (a)
· Operating
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.